# General Use-results Surveillance With Awiqli in Patients With Diabetes Mellitus

> **NCT06807190** · — · RECRUITING · sponsor: **Novo Nordisk A/S** · enrollment: 630 (estimated)

## Conditions studied

- Diabetes Mellitus, Type 1

## Interventions

- **DRUG:** Insulin Icodec

## Key facts

- **NCT ID:** NCT06807190
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-05-30
- **Primary completion:** 2027-07-31
- **Final completion:** 2028-01-31
- **Target enrollment:** 630 (ESTIMATED)
- **Last updated:** 2026-04-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06807190

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06807190, "General Use-results Surveillance With Awiqli in Patients With Diabetes Mellitus". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06807190. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*